U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown

Jan.11.2025
U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown
The Miami operation, announced on January 10, is the latest joint effort by multiple U.S. federal agencies to combat illegal e-cigarettes, resulting in the seizure of over $7 million worth of unauthorized products. The FDA emphasized that an “All Government” approach is critical in addressing the issue of illegal e-cigarettes.

Key Points:

 

1. This is another significant enforcement action following the October 2024 seizure of $76 million worth of illegal e-cigarettes.

 

2. Recently, the FDA has issued a series of announcements, including the January 3 announcement regarding updates to import alerts, allowing all unauthorized e-cigarettes to be detained without physical examination. These actions signal an acceleration of the FDA’s crackdown on illegal e-cigarettes.

 

3. In this announcement, Geek Bar was once again the only brand explicitly named, with the FDA stating that it “may appeal to youth.” This underscores the FDA’s close attention to the brand.

 

4. The details disclosed in this announcement—such as the seizure in Miami and the methods by which illegal products entered the U.S.—demonstrate the increasing precision and efficiency of enforcement under multi-agency cooperation.

 

5. The head of the FDA’s Center for Tobacco Products emphasized the importance of the “All Government” approach, in combating illegal e-cigarettes. This suggests that additional cases of illegal e-cigarette seizures may occur in the future.

 

 

 

[January 10, 2025] U.S. federal agencies announced the seizure of more than 628,000 unauthorized e-cigarette products from a warehouse in Miami, with a retail value exceeding $7 million. The confiscated items included flavored disposable e-cigarettes, kits, and batteries, with some products from brands like Geek Bar, which are known to appeal to youth.

 

The operation, led by U.S. Customs and Border Protection (CBP), uncovered shipments of illegal e-cigarette products originating from China and destined for various U.S. states. Investigations revealed that these products were intentionally misdeclared and undervalued—common tactics to evade detection and duties. Following referrals to the FDA’s Center for Tobacco Products, authorities confirmed the products lacked mandatory premarket authorization, rendering them illegal for sale or distribution in the U.S.

 

“An ‘All Government’ approach is critical to preventing unauthorized e-cigarettes from entering the United States” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Today’s action is another step in the right direction, and we remain committed to continuing to work with our federal partners to continue to combat the entry of these illegal products head on.”

 

Confiscated products, like those seized in this operation, are typically disposed of in compliance with federal regulations. For unauthorized tobacco products, including e-cigarettes, this generally means destruction.

 

The Miami operation is part of an intensified federal crackdown on illegal e-cigarette distribution. It follows a $76 million seizure of unauthorized e-cigarettes in October 2024 and builds on efforts spearheaded by a federal task force established in June 2024 to streamline enforcement. These coordinated actions aim to hold violators accountable by leveraging criminal and civil tools across multiple agencies.

 

To date, the FDA has authorized only 34 e-cigarette products and devices for legal sale in the U.S. More information on authorized tobacco products can be found in the FDA’s Searchable Tobacco Products Database.

 

Original FDA Announcement : Over $7 Million Worth of Illegal E-Cigarettes Seized in Federal Operation

 

 

 

2Firsts Editorial Note:

 

Since the second half of 2024, U.S. agencies have continued their crackdown on illegal e-cigarettes. Through coordinated efforts across multiple federal departments, these enforcement actions have achieved increasingly significant results, reflecting the U.S. federal government’s determination and strategic optimization in combating illegal e-cigarettes.

 

2Firsts has been closely monitoring U.S. regulatory actions on e-cigarettes. At the recently concluded 2Firsts 2024 Global NGP Compliance Development Symposium, 2Firsts invited several U.S. compliance experts to provide detailed insights into U.S. compliance policies for e-cigarette companies. Additionally, in 2Firsts’ 2024 Global Top 10 NGP News, the story titled “1. U.S. E-Cigarette Regulations Intensify, Setting the Stage for a Major Market Shakeup” ranked first.

 

 

 

Recent 2Firsts reports on U.S. regulations include:

 

1.FDA Strengthens Import Alerts to Address Unauthorized E-Cigarettes Detention

 

2.FDA Warns 9 Online Firms for Illegally Selling Flavored, Disposable E-Cigarettes, Including Geek Bar and Lost Mary

 

3.FDA Outlines Recent Regulatory Actions to 2Firsts: Comprehensive Oversight and Strategies Adapting to Market Changes


4.U.S. FDA's 2024 Illicit E-Cigarette Crackdown: Full-Spectrum Enforcement and Targeted Actions Against Geekvape and Heaven Gifts

 

5.FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR

 

6.U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts

 


 

2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

 

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden is expected to oppose a European Union proposal to raise minimum tobacco excise duties, Law360 reported on October 26, 2026, citing an EU official. A provisional Council agenda dated October 23 confirms that the tobacco taxation package is scheduled for discussion at the November 9 finance ministers' meeting, where member states will seek a general approach. The proposed reforms would raise minimum taxes on conventional tobacco products and establish EU-wide excise rules for vaping liquids, heated tobacco and nicotine pouches. Sweden supports harmonising tobacco taxation rules but objects to requiring nicotine pouches to bear the same minimum tax burden as certain smoking tobacco products. As EU indirect tax legislation requires unanimous Council approval, Swedish opposition could block the proposal in its current form.
Regulations
Oct.29
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives